The cytotoxicity of the compounds and cisplatin was tested against cancer cell lines: mouse colon carcinoma (CT26; <sup>1-PSG</sup>IC<sub>50</sub> = 3.12 ± 0.1), human lung adenocarcinoma (A549; <sup>1-PSG</sup>IC<sub>50</sub> = 2.01 ± 0.2) and human breast adenocarcinoma (MCF7; <sup>1-PSG</sup>IC<sub>50</sub> = 0.98 ± 0.2) as well as against primary line of human pulmonary fibroblasts (MRC-5; <sup>1-PSG</sup>IC<sub>50</sub> = 78.56 ± 1.1).